Proactiveinvestors USA & Canada Bristol-Myers Squibb Co https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Bristol-Myers Squibb Co RSS feed en Thu, 19 Sep 2019 22:06:14 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - LATE MOVERS: Tesla shares slip after news of $35,000 Model 3’s launch ]]> https://www.proactiveinvestors.com/companies/news/215560/late-movers-tesla-shares-slip-after-news-of-35000-model-3s-launch-215560.html Thu, 28 Feb 2019 13:33:00 -0500 https://www.proactiveinvestors.com/companies/news/215560/late-movers-tesla-shares-slip-after-news-of-35000-model-3s-launch-215560.html <![CDATA[News - MORNING MOVERS: Celgene crashes as Bristol-Myers takeover thrown into doubt ]]> https://www.proactiveinvestors.com/companies/news/215533/morning-movers-celgene-crashes-as-bristol-myers-takeover-thrown-into-doubt-215533.html Thu, 28 Feb 2019 08:11:00 -0500 https://www.proactiveinvestors.com/companies/news/215533/morning-movers-celgene-crashes-as-bristol-myers-takeover-thrown-into-doubt-215533.html <![CDATA[News - Heat Biologics expands its Phase 2 trial in combination with Merck’s Keytruda to treat non-small cell lung cancer ]]> https://www.proactiveinvestors.com/companies/news/311894/heat-biologics-expands-its-phase-2-trial-in-combination-with-mercks-keytruda-to-treat-non-small-cell-lung-cancer-11894.html Fri, 18 Jan 2019 11:12:00 -0500 https://www.proactiveinvestors.com/companies/news/311894/heat-biologics-expands-its-phase-2-trial-in-combination-with-mercks-keytruda-to-treat-non-small-cell-lung-cancer-11894.html <![CDATA[News - Eli Lilly’s $8B bet on Loxo is a ‘vote of confidence’ for novel scientific approaches that use DNA to treat cancer ]]> https://www.proactiveinvestors.com/companies/news/212091/eli-lillys-8b-bet-on-loxo-is-a-vote-of-confidence-for-novel-scientific-approaches-that-use-dna-to-treat-cancer-212091.html Mon, 07 Jan 2019 15:56:00 -0500 https://www.proactiveinvestors.com/companies/news/212091/eli-lillys-8b-bet-on-loxo-is-a-vote-of-confidence-for-novel-scientific-approaches-that-use-dna-to-treat-cancer-212091.html <![CDATA[News - EARLY MOVERS - Loxo Oncology shares skyrocket on news of Eli Lilly acquisition; DXC Technology to buy Luxoft Holding ]]> https://www.proactiveinvestors.com/companies/news/212063/early-movers---loxo-oncology-shares-skyrocket-on-news-of-eli-lilly-acquisition-dxc-technology-to-buy-luxoft-holding-212063.html Mon, 07 Jan 2019 08:03:00 -0500 https://www.proactiveinvestors.com/companies/news/212063/early-movers---loxo-oncology-shares-skyrocket-on-news-of-eli-lilly-acquisition-dxc-technology-to-buy-luxoft-holding-212063.html <![CDATA[News - Baird analysts stay Neutral on biotech sector as 2019 gets underway ]]> https://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html Fri, 04 Jan 2019 08:50:00 -0500 https://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html <![CDATA[News - Biotech CEOs see Bristol-Myers' $74B acquisition of Celgene as a win ]]> https://www.proactiveinvestors.com/companies/news/211926/biotech-ceos-see-bristol-myers--74b-acquisition-of-celgene-as-a-win-211926.html Thu, 03 Jan 2019 11:52:00 -0500 https://www.proactiveinvestors.com/companies/news/211926/biotech-ceos-see-bristol-myers--74b-acquisition-of-celgene-as-a-win-211926.html <![CDATA[News - EARLY MOVERS: Celgene rallies as Bristol-Myers offers to buy cancer drug company ]]> https://www.proactiveinvestors.com/companies/news/211911/early-movers-celgene-rallies-as-bristol-myers-offers-to-buy-cancer-drug-company-211911.html Thu, 03 Jan 2019 08:04:00 -0500 https://www.proactiveinvestors.com/companies/news/211911/early-movers-celgene-rallies-as-bristol-myers-offers-to-buy-cancer-drug-company-211911.html <![CDATA[News - Mirati Therapeutics shares tumble on release of Phase 2 trial data for lung cancer treatment ]]> https://www.proactiveinvestors.com/companies/news/207600/mirati-therapeutics-shares-tumble-on-release-of-phase-2-trial-data-for-lung-cancer-treatment-207600.html Mon, 22 Oct 2018 14:14:00 -0400 https://www.proactiveinvestors.com/companies/news/207600/mirati-therapeutics-shares-tumble-on-release-of-phase-2-trial-data-for-lung-cancer-treatment-207600.html <![CDATA[News - Bristol-Myers Squibb shares fall after FDA delays approval for lung cancer therapy ]]> https://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html Mon, 22 Oct 2018 11:36:00 -0400 https://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html <![CDATA[News - How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer ]]> https://www.proactiveinvestors.com/companies/news/207017/how-genprex-took-an-abandoned-pipeline-drug-and-turned-it-into-oncoprex-an-innovative-treatment-for-non-small-cell-lung-cancer-207017.html Fri, 12 Oct 2018 13:52:00 -0400 https://www.proactiveinvestors.com/companies/news/207017/how-genprex-took-an-abandoned-pipeline-drug-and-turned-it-into-oncoprex-an-innovative-treatment-for-non-small-cell-lung-cancer-207017.html <![CDATA[News - Bristol-Myers Squibb makes $12 million investment in Compugen, sets up research partnership ]]> https://www.proactiveinvestors.com/companies/news/206931/bristol-myers-squibb-makes-12-million-investment-in-compugen-sets-up-research-partnership-206931.html Thu, 11 Oct 2018 13:54:00 -0400 https://www.proactiveinvestors.com/companies/news/206931/bristol-myers-squibb-makes-12-million-investment-in-compugen-sets-up-research-partnership-206931.html <![CDATA[News - EARLY MOVERS: Square shares fall and Compugen shares surge on Bristol-Myers Squibb investment as stock markets in turmoil ]]> https://www.proactiveinvestors.com/companies/news/206898/early-movers-square-shares-fall-and-compugen-shares-surge-on-bristol-myers-squibb-investment-as-stock-markets-in-turmoil-206898.html Thu, 11 Oct 2018 08:07:00 -0400 https://www.proactiveinvestors.com/companies/news/206898/early-movers-square-shares-fall-and-compugen-shares-surge-on-bristol-myers-squibb-investment-as-stock-markets-in-turmoil-206898.html <![CDATA[News - EARLY MOVERS: Bristol-Myers Squibb shares spurt higher on FDA news, but Tesla Inc shares lose power ]]> https://www.proactiveinvestors.com/companies/news/203146/early-movers-bristol-myers-squibb-shares-spurt-higher-on-fda-news-but-tesla-inc-shares-lose-power-203146.html Fri, 17 Aug 2018 08:01:00 -0400 https://www.proactiveinvestors.com/companies/news/203146/early-movers-bristol-myers-squibb-shares-spurt-higher-on-fda-news-but-tesla-inc-shares-lose-power-203146.html <![CDATA[News - Merck's 2Q earnings beat Street with sales turbocharged by cancer drug Keytruda ]]> https://www.proactiveinvestors.com/companies/news/201752/merck-s-2q-earnings-beat-street-with-sales-turbocharged-by-cancer-drug-keytruda-201752.html Fri, 27 Jul 2018 08:53:00 -0400 https://www.proactiveinvestors.com/companies/news/201752/merck-s-2q-earnings-beat-street-with-sales-turbocharged-by-cancer-drug-keytruda-201752.html <![CDATA[News - Bristol-Myers Squibb's 2Q earnings beat Street on healthy sales of its blockbuster cancer drug Opdivo ]]> https://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html Thu, 26 Jul 2018 11:41:00 -0400 https://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html <![CDATA[News - PRE-MARKET MOVERS: Smartphone giant BlackBerry leaps ahead of bell after quarterly results ]]> https://www.proactiveinvestors.com/companies/news/199407/pre-market-movers-smartphone-giant-blackberry-leaps-ahead-of-bell-after-quarterly-results-199407.html Fri, 22 Jun 2018 07:57:00 -0400 https://www.proactiveinvestors.com/companies/news/199407/pre-market-movers-smartphone-giant-blackberry-leaps-ahead-of-bell-after-quarterly-results-199407.html <![CDATA[News - Cancer doctors offer key takeaways from American Society of Clinical Oncology conference ]]> https://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html Tue, 12 Jun 2018 16:29:00 -0400 https://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html <![CDATA[News - Small-Cap Snapshot: Corindus inks deal to branch out to Japan, Funko investors file class-action suit ]]> https://www.proactiveinvestors.com/companies/news/198557/small-cap-snapshot-corindus-inks-deal-to-branch-out-to-japan-funko-investors-file-class-action-suit-198557.html Fri, 08 Jun 2018 10:59:00 -0400 https://www.proactiveinvestors.com/companies/news/198557/small-cap-snapshot-corindus-inks-deal-to-branch-out-to-japan-funko-investors-file-class-action-suit-198557.html <![CDATA[News - Bristol Myers Squibb showcases positive results of new Phase 3 study evaluating cancer drug Opdivo ]]> https://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html Mon, 04 Jun 2018 08:04:00 -0400 https://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html <![CDATA[News - Jounce Therapeutics shares plunge on scant details about its Phase 1/2 ICONIC trial ]]> https://www.proactiveinvestors.com/companies/news/197211/jounce-therapeutics-shares-plunge-on-scant-details-about-its-phase-12-iconic-trial-197211.html Thu, 17 May 2018 09:54:00 -0400 https://www.proactiveinvestors.com/companies/news/197211/jounce-therapeutics-shares-plunge-on-scant-details-about-its-phase-12-iconic-trial-197211.html <![CDATA[News - Bristol-Myers beats 1Q estimates, guides higher for full-year 2018 on drug approvals ]]> https://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html Thu, 26 Apr 2018 08:18:00 -0400 https://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html <![CDATA[News - Wall Street ends on a high as reporting season cheer continues ]]> https://www.proactiveinvestors.com/companies/news/195174/wall-street-ends-on-a-high-as-reporting-season-cheer-continues Tue, 17 Apr 2018 13:38:00 -0400 https://www.proactiveinvestors.com/companies/news/195174/wall-street-ends-on-a-high-as-reporting-season-cheer-continues <![CDATA[News - US benchmarks close higher as earnings season points to strong growth ]]> https://www.proactiveinvestors.com/companies/news/194952/us-benchmarks-close-higher-as-earnings-season-points-to-strong-growth-194952.html Mon, 16 Apr 2018 13:39:00 -0400 https://www.proactiveinvestors.com/companies/news/194952/us-benchmarks-close-higher-as-earnings-season-points-to-strong-growth-194952.html <![CDATA[News - Merck shares pop as its Keytruda drug results power ahead of Bristol-Myers, Roche ]]> https://www.proactiveinvestors.com/companies/news/195075/merck-shares-pop-as-its-keytruda-drug-results-power-ahead-of-bristol-myers-roche-195075.html Mon, 16 Apr 2018 11:24:00 -0400 https://www.proactiveinvestors.com/companies/news/195075/merck-shares-pop-as-its-keytruda-drug-results-power-ahead-of-bristol-myers-roche-195075.html <![CDATA[News - Bristol-Myers falls after Citi analyst says Pfizer not interested in buying the drugmaker ]]> https://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html Thu, 12 Apr 2018 12:52:00 -0400 https://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html <![CDATA[News - Bristol-Myers Squibb’s new dosing for cancer drug Opdivo gets FDA green light ]]> https://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html Tue, 06 Mar 2018 07:49:00 -0500 https://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html <![CDATA[News - Bristol-Myers Squibb, Cirrus Logic, Arconic Inc, SYSCO and more - PRE-MARKET ]]> https://www.proactiveinvestors.com/companies/news/191154/bristol-myers-squibb-cirrus-logic-arconic-inc-sysco-and-more-pre-market-191154.html Mon, 05 Feb 2018 08:17:00 -0500 https://www.proactiveinvestors.com/companies/news/191154/bristol-myers-squibb-cirrus-logic-arconic-inc-sysco-and-more-pre-market-191154.html <![CDATA[News - Bristol-Myers shares on the uptick after positive lung cancer trial results and market beating fourth quarter results ]]> https://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html Mon, 05 Feb 2018 08:04:00 -0500 https://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html <![CDATA[News - Merck shares continue to rise after successful lung cancer trial ]]> https://www.proactiveinvestors.com/companies/news/190178/merck-shares-continue-to-rise-after-successful-lung-cancer-trial-190178.html Wed, 17 Jan 2018 09:00:00 -0500 https://www.proactiveinvestors.com/companies/news/190178/merck-shares-continue-to-rise-after-successful-lung-cancer-trial-190178.html <![CDATA[News - Bristol-Myers Squibb drops on surprise third quarter profits miss ]]> https://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html Thu, 26 Oct 2017 08:37:00 -0400 https://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html <![CDATA[News - Halozyme Therapeutics stock to surge thanks to Bristol-Myers licensing deal ]]> https://www.proactiveinvestors.com/companies/news/183993/halozyme-therapeutics-stock-to-surge-thanks-to-bristol-myers-licensing-deal-183993.html Thu, 14 Sep 2017 07:41:00 -0400 https://www.proactiveinvestors.com/companies/news/183993/halozyme-therapeutics-stock-to-surge-thanks-to-bristol-myers-licensing-deal-183993.html <![CDATA[News - Bristol Myers Squibb kidney cancer treatment meets endpoint of late-stage trial ]]> https://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html Thu, 07 Sep 2017 14:31:00 -0400 https://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html <![CDATA[News - L Brands, Agilent Technologies, Bristol-Myers Squibb Co and more - AFTER HOURS ]]> https://www.proactiveinvestors.com/companies/news/182540/l-brands-agilent-technologies-bristol-myers-squibb-co-and-more-after-hours-182540.html Wed, 16 Aug 2017 08:06:00 -0400 https://www.proactiveinvestors.com/companies/news/182540/l-brands-agilent-technologies-bristol-myers-squibb-co-and-more-after-hours-182540.html <![CDATA[News - Array Biopharma and Bristol Myers to work on colorectal cancer combo therapy ]]> https://www.proactiveinvestors.com/companies/news/178497/array-biopharma-and-bristol-myers-to-work-on-colorectal-cancer-combo-therapy-178497.html Tue, 30 May 2017 14:40:00 -0400 https://www.proactiveinvestors.com/companies/news/178497/array-biopharma-and-bristol-myers-to-work-on-colorectal-cancer-combo-therapy-178497.html <![CDATA[News - Bristol Myers Squibb buoyed by surge in sales of key drugs ]]> https://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html Thu, 27 Apr 2017 14:07:00 -0400 https://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html <![CDATA[News - Bristol-Myers enters into two license deals with Biogen and Roche worth up to US$1.1bn ]]> https://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html Thu, 13 Apr 2017 08:48:00 -0400 https://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html <![CDATA[News - CytomX Therapeutics shoots higher as it's set for US$200mln upfront payment from Bristol-Myers Squibb ]]> https://www.proactiveinvestors.com/companies/news/175079/cytomx-therapeutics-shoots-higher-as-it-s-set-for-us200mln-upfront-payment-from-bristol-myers-squibb-175079.html Mon, 20 Mar 2017 14:32:00 -0400 https://www.proactiveinvestors.com/companies/news/175079/cytomx-therapeutics-shoots-higher-as-it-s-set-for-us200mln-upfront-payment-from-bristol-myers-squibb-175079.html <![CDATA[News - Bristol-Myers shares hit by new lung cancer disappointment ]]> https://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html Fri, 20 Jan 2017 13:57:00 -0500 https://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html <![CDATA[News - US stocks trend higher, but unfazed by Trump’s damp inauguration ]]> https://www.proactiveinvestors.com/companies/news/171955/us-stocks-trend-higher-but-unfazed-by-trumps-damp-inauguration-171955.html Fri, 20 Jan 2017 08:56:00 -0500 https://www.proactiveinvestors.com/companies/news/171955/us-stocks-trend-higher-but-unfazed-by-trumps-damp-inauguration-171955.html <![CDATA[News - US shares end up as oil investors crowd out depressed pharma post-Trump speech ]]> https://www.proactiveinvestors.com/companies/news/171478/us-shares-end-up-as-oil-investors-crowd-out-depressed-pharma-post-trump-speech-171478.html Wed, 11 Jan 2017 08:30:00 -0500 https://www.proactiveinvestors.com/companies/news/171478/us-shares-end-up-as-oil-investors-crowd-out-depressed-pharma-post-trump-speech-171478.html <![CDATA[News - Bristol-Myers announces results for Opdivo ]]> https://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html Tue, 06 Dec 2016 16:26:00 -0500 https://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html <![CDATA[News - US stocks close lower as a bonds rout indicates Dec rate hike ]]> https://www.proactiveinvestors.com/companies/news/168151/us-stocks-close-lower-as-a-bonds-rout-indicates-dec-rate-hike-168151.html Thu, 27 Oct 2016 08:48:00 -0400 https://www.proactiveinvestors.com/companies/news/168151/us-stocks-close-lower-as-a-bonds-rout-indicates-dec-rate-hike-168151.html <![CDATA[News - Healthy oil rise keeps markets afloat, helps energy stocks ]]> https://www.proactiveinvestors.com/companies/news/129127/healthy-oil-rise-keeps-markets-afloat-helps-energy-stocks-129127.html Mon, 08 Aug 2016 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/129127/healthy-oil-rise-keeps-markets-afloat-helps-energy-stocks-129127.html <![CDATA[News - US markets ease back from record levels ]]> https://www.proactiveinvestors.com/companies/news/129124/us-markets-ease-back-from-record-levels-129124.html Mon, 08 Aug 2016 10:53:00 -0400 https://www.proactiveinvestors.com/companies/news/129124/us-markets-ease-back-from-record-levels-129124.html <![CDATA[News - US shares mark record highs after NFP upside surprise ]]> https://www.proactiveinvestors.com/companies/news/129090/us-shares-mark-record-highs-after-nfp-upside-surprise-129090.html Fri, 05 Aug 2016 17:07:00 -0400 https://www.proactiveinvestors.com/companies/news/129090/us-shares-mark-record-highs-after-nfp-upside-surprise-129090.html <![CDATA[News - Records broken by S&P 500, S&P 400 and S&P 600 indexes after forecast-beating NFP ]]> https://www.proactiveinvestors.com/companies/news/129082/records-broken-by-sp-500-sp-400-and-sp-600-indexes-after-forecast-beating-nfp-129082.html Fri, 05 Aug 2016 13:32:00 -0400 https://www.proactiveinvestors.com/companies/news/129082/records-broken-by-sp-500-sp-400-and-sp-600-indexes-after-forecast-beating-nfp-129082.html <![CDATA[News - Bristol Myers slumps as immunotherapy drug fails lung cancer trial ]]> https://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html Fri, 05 Aug 2016 10:02:00 -0400 https://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html <![CDATA[News - Brokers: Jefferies warming to Baker-Hughes's strategy shift ]]> https://www.proactiveinvestors.com/companies/news/275610/brokers-jefferies-warming-to-baker-hughes-s-strategy-shift-25610.html Fri, 29 Jul 2016 09:45:00 -0400 https://www.proactiveinvestors.com/companies/news/275610/brokers-jefferies-warming-to-baker-hughes-s-strategy-shift-25610.html <![CDATA[News - Bristol Myers/ Janssen target lung cancer with I-O combo ]]> https://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html Tue, 26 Jul 2016 08:55:00 -0400 https://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html